🔎 Trials Near Me

Akèy › Kansè pankreyas › South Carolina › Charleston

Etid klinik pou Kansè pankreyas nan Charleston, SC

7 etid pou Kansè pankreyas ap chèche patisipan nan sit nan ak bò kote Charleston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

Ap rekriteFaz 3
  • Investigative Site US082, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07522073

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Ap rekriteEtid obsèvasyon
  • Roper Hospital, Charleston
  • Bon Secours Saint Francis Hospital, Charleston
Laj 50 a 75 · Tout sèks · Mizajou Sep 4, 2026 · NCT04239573

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Ap rekriteFaz 3
  • Medical University of South Carolina, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT06958328

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

Ap rekriteFaz 2
  • Medical University of South Carolina, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT06937177

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Ap rekriteFaz 2
  • Ohio State University-Telemedicine, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Feb 17, 2026 · NCT06906562

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Medical University of South Carolina, Charleston
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Ap rekriteFaz 1
  • Medical University of South Carolina, Hollings Cancer Center, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Aug 15, 2025 · NCT04429542

Etid Kansè pankreyas nan lòt vil

Lòt etid nan Charleston

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.